Precipio (NASDAQ:PRPO – Get Free Report) and Mobile-health Network Solutions (NASDAQ:MNDR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.
Insider and Institutional Ownership
10.4% of Precipio shares are owned by institutional investors. 16.9% of Precipio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current recommendations and price targets for Precipio and Mobile-health Network Solutions, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
| Mobile-health Network Solutions | 1 | 0 | 0 | 0 | 1.00 |
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Precipio | -5.50% | -10.07% | -6.71% |
| Mobile-health Network Solutions | N/A | N/A | N/A |
Earnings & Valuation
This table compares Precipio and Mobile-health Network Solutions”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Precipio | $22.80 million | 1.93 | -$4.29 million | ($0.82) | -30.61 |
| Mobile-health Network Solutions | $7.65 million | 0.13 | -$3.38 million | N/A | N/A |
Mobile-health Network Solutions has lower revenue, but higher earnings than Precipio.
Risk & Volatility
Precipio has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Mobile-health Network Solutions has a beta of -2.17, suggesting that its stock price is 317% less volatile than the S&P 500.
Summary
Precipio beats Mobile-health Network Solutions on 5 of the 9 factors compared between the two stocks.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
About Mobile-health Network Solutions
Mobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore. The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children's health services, geriatric care services, and minor surgical procedures. In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services. The company was founded in 2009 and is headquartered in Singapore.
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
